Results 181 to 190 of about 47,357 (307)

Outpatient preoperative parenteral nutrition in malnourished surgical patients: A feasibility study (the OPPORTUNITY study)

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Preoperative parenteral nutrition (PN) improves outcomes in malnourished surgical patients. Traditionally, this requires hospital admission, increasing length of stay and costs—challenges worsened by limited hospital bed availability. Outpatient PN may offer a feasible alternative.
Narisorn Lakananurak, Leah Gramlich
wiley   +1 more source

Physical Activity and Prevalence of Functional Dyspepsia in Adults: A Cross-Sectional Study. [PDF]

open access: yesInt J Prev Med
Tavasoli P   +7 more
europepmc   +1 more source

Identifying DASH Adherence Patterns and Their Association With Dietary Behaviors Among Adults With Hypertension

open access: yesResearch in Nursing &Health, EarlyView.
ABSTRACT The Dietary Approaches to Stop Hypertension (DASH) diet is effective in lowering blood pressure yet adherence to DASH remains low. Intuitive eating, a behavior that emphasizes responsiveness to hunger and satiety cues, may influence DASH adherence but has not been well studied among adults with hypertension.
Youran Lee   +7 more
wiley   +1 more source

Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis

open access: yesObesity, EarlyView.
ABSTRACT Objective This meta‐analysis evaluates the safety and efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) for the treatment of older adults with obesity compared to younger individuals. Methods A systematic review was conducted following PRISMA guidelines (PROSPERO CRD420251074381).
Inês Rego de Figueiredo   +4 more
wiley   +1 more source

Deciphering obesity: a conceptual overview and synthesis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Prakash R, Arora A, Khan A.
europepmc   +1 more source

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

open access: yesObesity, EarlyView.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim   +3 more
wiley   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

open access: yesObesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone   +3 more
wiley   +1 more source

Comparative Analysis of the Daily Liver Metabolomics of Asian Particolored Bat. [PDF]

open access: yesEcol Evol
Chu Y   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy